Giuseppe Limongelli

Active 1998–2025

176
Papers
20,047
Citations
65
h-index
156
i10-index

Citations

Citations per year for Giuseppe Limongelli1955: 1 citations1982: 1 citations1991: 2 citations1998: 2 citations1999: 2 citations2000: 2 citations2001: 3 citations2002: 1 citations2003: 1 citations2004: 1 citations2005: 2 citations2006: 2 citations2007: 6 citations2008: 19 citations2009: 19 citations2010: 35 citations2011: 39 citations2012: 34 citations2013: 21 citations2014: 57 citations2015: 100 citations2016: 102 citations2017: 133 citations2018: 131 citations2019: 521 citations2020: 711 citations2021: 826 citations2022: 651 citations2023: 477 citations2024: 1,137 citations2025: 499 citations2026: 15 citations1956–1981: no citations, so these years are not shown1983–1990: no citations, so these years are not shown1992–1997: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,419 citing papers, 15.7% of this breakdownItaly: 1,159 citing papers, 12.8% of this breakdownUnited Kingdom: 820 citing papers, 9.1% of this breakdownChina: 514 citing papers, 5.7% of this breakdownGermany: 489 citing papers, 5.4% of this breakdownNetherlands: 413 citing papers, 4.6% of this breakdownSpain: 319 citing papers, 3.5% of this breakdownFrance: 310 citing papers, 3.4% of this breakdownCanada: 302 citing papers, 3.4% of this breakdownAustralia: 216 citing papers, 2.4% of this breakdownSwitzerland: 199 citing papers, 2.2% of this breakdownBelgium: 187 citing papers, 2.1% of this breakdown
0%15.7%Other 29.7%

Fields

  • Medicine81.1%
  • Biochemistry, Genetics and Molecular Biology13.8%
  • Immunology and Microbiology1.2%
  • Engineering0.9%
  • Neuroscience0.7%
  • Nursing0.4%
  • Other1.9%

Topics

  • Cardiomyopathy and Myosin Studies12.6%
  • Cardiovascular Function and Risk Factors9.2%
  • Cardiovascular Effects of Exercise6.4%
  • Cardiac Imaging and Diagnostics3.6%
  • Cardiac electrophysiology and arrhythmias3.3%
  • Cardiac pacing and defibrillation studies2.4%
  • Other62.5%

Coauthors

All papers

Open in search
  1. 2023 ESC Guidelines for the management of cardiomyopathies

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Magdy Abdelhamid, Victor Aboyans, Michael Arad, Folkert W. Asselbergs, Riccardo Asteggiano, Zofia T. Bilińska, Damien Bonnet, Henning Bundgaard, Nuno Cardim, Jelena Čelutkienė, Maja Čikeš, Gaetano Maria De Ferrari, Veronica Dusi, Volkmar Falk, Laurent Fauchier, Estelle Gandjbakhch, Tiina Heliö, Konstantinos C. Koskinas, Dipak Kotecha, Ulf Landmesser, George Lazaros, Basil S. Lewis, Aleš Linhart, Maja‐Lisa Løchen, Benjamin Meder, Richard Mindham, James Moon, Jens Cosedis Nielsen, Steffen E. Petersen, Eva Prescott, Mary N. Sheppard, Gianfranco Sinagra, Marta Sitges, Jacob Tfelt‐Hansen, Rhian M. Touyz, Rogier J. A. Veltrop, Josef Veselka, Karim Wahbi, Arthur A.M. Wilde, Katja Zeppenfeld, B. Kichou, Hamayak Sisakian, Daniel Scherr, Bernhard Gerber, Alen Džubur, Мариана Господинова, Ivo Planinc, Hera Heracleous Moustra, David Zemánek, Morten K. Jensen, Ahmad Samir, Kairit Palm, Tiina Heliö, Karim Wahbi, Eric Schulze‐Bahr, Vlachopoulos Haralambos, Róbert Sepp, Berglind Aðalsteinsdóttir, Deirdre Ward, Miry Blich, Gianfranco Sinagra, Afrim Poniku, Olga Lunegova, Ainārs Rudzītis, Roland Kassab, Jūratė Barysienė, Steve Huijnen, Tiziana Felice, Eleonora Vataman, Nikola Pavlović and 41 more - European Heart Journal 2023 cited by 2,384

  2. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy

    Authors: , , , , , , , , , , , , , , , , , , , , - European Heart Journal 2014 cited by 4,317

  3. Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice: a position statement of the ESC working group on myocardial and pericardial diseases

    Authors: , , , , , , , , , , , , , , , , , , , , , , - European Heart Journal 2016 cited by 1,084

  4. A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM Risk-SCD)

    Authors: , , , , , , , , , , , , - European Heart Journal 2013 cited by 1,220

  5. Heart Failure in Cardiomyopathies: A Position Paper from the Heart Failure Association of the European Society of Cardiology

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Frank Ruschitzka, Jelena Čelutkienė, Tiny Jaarsma, Christian Mueller, Brenda Moura, Loreena Hill, Maurizio Volterrani, Yu. M. Lopatin, Marco Metra, Johannes Backs, Wilfried Müllens, Ovidiu Chioncel, Rudolf A. de Boer, Stefan D. Anker, Claudio Rapezzi, Andrew J.S. Coats, Carsten Tschöpe - European Journal of Heart Failure 2019 cited by 377

  6. Inflammation and Cardiovascular Disease: From Pathogenesis to Therapeutic Target

    Authors: , , , , , , , , , , , , , , , - Current Atherosclerosis Reports 2014 cited by 581

  7. An Expert Consensus Document on the Management of Cardiovascular Manifestations of Fabry Disease

    Authors: , , , , , , , , , , , , - European Journal of Heart Failure 2020 cited by 219

  8. Development of a Novel Risk Prediction Model for Sudden Cardiac Death in Childhood Hypertrophic Cardiomyopathy (HCM Risk-Kids)

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Roberto Barriales‐Villa, Luis Garcı́a-Guereta, Satish Adwani, Katie Linter, Tara Bharucha, Pablo García‐Pavía, Torsten B. Rasmussen, Margherita Calcagnino, Caroline B. Jones, Hans De Wilde, J. Toru-Kubo, Tiziana Felice, Jens Mogensen, Sujeev Mathur, Zdenka Reinhardt, Constantinos O’Mahony, Perry Elliott, Rumana Omar, Juan Pablo Kaski - JAMA Cardiology 2019 cited by 250

  9. Treatments targeting inotropy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Christian Mueller, Burkert Pieske, Piotr Ponikowski, Arsen Ristić, Frank Ruschitzka, Petar Seferović, Hadi Skouri, Wolfram H. Zimmermann, Alexandre Mebazaa - European Heart Journal 2018 cited by 226

  10. Exercise Stress Echocardiography of the Right Ventricle and Pulmonary Circulation

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Alberto M. Marra, Marco Matucci‐Cerinic, Ciro Mauro, Antonella Moreo, Lorenza Pratali, Brigida Ranieri, Salvatore Rega, Lawrence Rudski, Rajan Saggar, Andrea Salzano, Walter Serra, Anna Agnese Stanziola, Mani A. Vannan, Damien Voilliot, Olga Vriz, Karina Wierzbowska‐Drabik, Antonio Cittadini, Robert Naeije, Eduardo Bossone, Eduardo Bossone, Luna Gargani, Robert Naeije, Francesco Ferrara, William F. Armstrong, Theodore J. Kolias, Valentina Capone, Rosangela Cocchia, Ciro Mauro, Chiara Sepe, Filippo Cademartiri, Iacopo Fabiani, Francesco Capuano, Rodolfo Citro, Rossella Maria Benvenga, Michele Bellino, Giuseppe Iuliano, Serena Migliarino, Ilaria Radano, Antonio Cittadini, Michele Arcopinto, Alberto M. Marra, Giulia Crisci, Roberta D’Assante, Mariarosaria De Luca, Federica Giardino, Carmen Rainone, Salvatore Rega, Valéria Valente, Michele D’Alto, Paola Argiento, Antonello D’Andrea, Francesco Ferrara, Valentina Russo, Luna Gargani, Paolo Frumento, Matteo Mazzola, Santo Dellegrottaglie, Giovanni Di Salvo, Stefano Ghio, Stefania Guida, Ekkerard Grunig, Christina A. Eichstaedt, Marco Guazzi, Francesco Bandera, Valentina Labate, André La Gerch, Giuseppe Limongelli, Andreina Carbone, Giuseppe Pacileo, Marina Verrengia and 39 more - Journal of the American College of Cardiology 2023 cited by 81

  11. Unmasking the prevalence of amyloid cardiomyopathy in the real world: results from Phase 2 of the AC‐TIVE study, an Italian nationwide survey

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Francesco Bruno, Francesca Longo, Maddalena Rossi, Guerino Giuseppe Varrà, Riccardo Saro, Luca Di Ienno, Giuseppe De Carli, Elisa Giacomin, Chiara Arzilli, Giuseppe Limongelli, Camillo Autore, Iacopo Olivotto, Luigi P. Badano, Gianfranco Parati, Stefano Perlini, Marco Metra, Michele Emdin, Claudio Rapezzi, Gianfranco Sinagra - European Journal of Heart Failure 2022 cited by 91

  12. The Role of von Willebrand Factor in Vascular Inflammation: From Pathogenesis to Targeted Therapy

    Authors: , , , , , , , , , , , , , , - Mediators of Inflammation 2017 cited by 231

  13. Prediction of Thrombo-Embolic Risk in Patients with Hypertrophic Cardiomyopathy (HCM Risk-CVA)

    Authors: , , , , , , , , , , , , , - European Journal of Heart Failure 2015 cited by 159

  14. Bicuspid Aortic Valve

    Authors: , , , , , , , , , , , , , , , , , - Circulation 2014 cited by 432

  15. The Cardiomyopathy Registry of the EURObservational Research Programme of the European Society of Cardiology: baseline data and contemporary management of adult patients with cardiomyopathies

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Natalija Chakova, Przemysław Chmielewski, Fabrizio Drago, Attila Frigy, Andrea Frustaci, Pablo García‐Pavía, Saša Hinić, Ingrid Kindermann, Giuseppe Limongelli, Constancio Medrano, Lorenzo Monserrat, Akinsanya Olusegun‐Joseph, Tomás Ripoll‐Vera, Luís R. Lopes, Aly M A Saad, Simone Sala, Petar Seferović, Róbert Sepp, José Ángel Urbano-Moral, Eduardo Villacorta, Maciej Wybraniec, Raquel Yotti, Elisabetta Zachara, Esther Zorio - European Heart Journal 2018 cited by 142

  16. Clinical application of CMR in cardiomyopathies: evolving concepts and techniques

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Heart Failure Reviews 2022 cited by 70

  17. Athlete's Heart: A Cardiovascular Step-By-Step Multimodality Approach

    Authors: , , , , , , , , , , , , , , - Reviews in Cardiovascular Medicine 2023 cited by 57

  18. Multiple hormonal and metabolic deficiency syndrome predicts outcome in heart failure: the T.O.S.CA. Registry

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Raffaele Napoli, Toru Suzuki, Kim A. Eagle, Héctor O. Ventura, Alberto M. Marra, Eduardo Bossone, the T.O.S.CA. Investigators - European Journal of Preventive Cardiology 2021 cited by 57

  19. Hypertrophic Cardiomyopathy in RASopathies

    Authors: , , , , , , , , , , , , , , - Heart Failure Clinics 2021 cited by 73

  20. Impact of gliflozins on cardiac remodeling in patients with type 2 diabetes mellitus & reduced ejection fraction heart failure: A pilot prospective study. GLISCAR study

    Authors: , , , , , , , , , , , , , , - Diabetes Research and Clinical Practice 2023 cited by 28

  21. Heart Failure Patients with Improved Ejection Fraction: Insights from the MECKI Score Database

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Marco Cittar, Maria Vittoria Matassini, Andrea Salzano, Antonio Cittadini, Marco Masè, Francesco Bandera, Maurizio Bussotti, Irene Mattavelli, Federica Re, Carlo Vignati, Carlo Lombardi, Angela Beatrice Scardovi, Susanna Sciomer, Andrea Passantino, Michele Emdin, Andrea Di Lenarda, Claudio Passino, Caterina Santolamazza, Federica Moscucci, Denise Zaffalon, Massimo Piepoli - European Journal of Heart Failure 2023 cited by 26

  22. Mortality Among Referral Patients With Hypertrophic Cardiomyopathy vs the General European Population

    Authors: , , , , , , , , , , , , , - JAMA Cardiology 2019 cited by 121

  23. Predictors of atrial fibrillation in hypertrophic cardiomyopathy

    Authors: , , , , , , , , , , , , - Heart 2016 cited by 120

  24. Prognostic Implications of the Extent of Cardiac Damage in Patients With Fabry Disease

    Authors: , , , , , , , , , , , , , , , , , - Journal of the American College of Cardiology 2023 cited by 43